Literature DB >> 20590472

Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering.

Natalina Quarto1, Björn Behr, Michael T Longaker.   

Abstract

To delineate the competence window in which canonical wingless (Wnt)-signaling can either inhibit or promote osteogenic differentiation, we have analyzed cells with different status, specifically undifferentiated mesenchymal cells, such as adipose-derived stem cells and embryonic calvarial mesenchymal cells, and differentiated mesenchymal cells such as juvenile immature calvarial osteoblasts and adult calvarial osteoblasts. Our analysis indicated that undifferentiated mesenchymal cells and juvenile calvarial osteoblasts are endowed with higher levels of endogenous canonical Wnt signaling compared to fully differentiated adult calvarial osteoblasts, and that different levels of activation inversely correlated with expression levels of several Wnt antagonists. We have observed that activation of canonical Wnt signaling may elicit opposite biological activity in the context of osteogenic differentiation depending on the status of cell, the threshold levels of its activation, and Wnt ligands concentration. The results presented in this study indicate that treatment with Wnt3 and/or expression of constitutively activated β-catenin inhibits osteogenic differentiation of undifferentiated mesenchymal cells, whereas expression of dominant negative transcription factor 4 (Tcf4) and/or secreted frizzled related protein 1 treatment enhances their osteogenic differentiation. Wnt3a treatment also inhibits osteogenesis in juvenile calvarial osteoblasts in a dose-dependent fashion. Conversely, Wnt3a treatment strongly induces osteogenesis in mature calvarial osteoblasts in a dose-dependent manner. Importantly, in vitro data correlated with in vivo results showing that Wnt3a treatment of calvarial defects, created in juvenile mice, promotes calvarial healing and bone regeneration only at low doses, whereas high doses of Wnt3a impairs tissue regeneration. In contrast, high doses of Wnt3a enhance bony tissue regeneration and calvarial healing in adult mice. Therefore, the knowledge of both endogenous activity of canonical Wnt signaling and appropriate concentrations of Wnt3a treatment may lead to significant improvement for bony tissue engineering, as well as for the efficient implement of adipose-derived stem cells in bone regeneration. Indeed, this study has important potential implications for tissue engineering, specifically for repair of juvenile bone defects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590472      PMCID: PMC2947420          DOI: 10.1089/ten.tea.2010.0133

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  49 in total

Review 1.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 2.  Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy.

Authors:  D Baksh; L Song; R S Tuan
Journal:  J Cell Mol Med       Date:  2004 Jul-Sep       Impact factor: 5.310

Review 3.  Modulation of osteoclast differentiation.

Authors:  T Suda; N Takahashi; T J Martin
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

4.  Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.

Authors:  Theo P Hill; Daniela Später; Makoto M Taketo; Walter Birchmeier; Christine Hartmann
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

5.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.

Authors:  Timothy F Day; Xizhi Guo; Lisa Garrett-Beal; Yingzi Yang
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

Review 6.  Wnt signalling in stem cells and cancer.

Authors:  Tannishtha Reya; Hans Clevers
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

7.  Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice.

Authors:  J Galceran; I Fariñas; M J Depew; H Clevers; R Grosschedl
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

8.  Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.

Authors:  F T Kolligs; G Hu; C V Dang; E R Fearon
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

9.  Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.

Authors:  Genevieve M Boland; Geraldine Perkins; David J Hall; Rocky S Tuan
Journal:  J Cell Biochem       Date:  2004-12-15       Impact factor: 4.429

10.  The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal.

Authors:  N Quarto; F P Finger; D B Rifkin
Journal:  J Cell Physiol       Date:  1991-05       Impact factor: 6.384

View more
  19 in total

Review 1.  Stem cell-based tissue engineering approaches for musculoskeletal regeneration.

Authors:  Patrick T Brown; Andrew M Handorf; Won Bae Jeon; Wan-Ju Li
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 2.  Review of biophysical factors affecting osteogenic differentiation of human adult adipose-derived stem cells.

Authors:  Georgina To'a Salazar; Osamu Ohneda
Journal:  Biophys Rev       Date:  2012-05-22

3.  Chondrogenic, hypertrophic, and osteochondral differentiation of human mesenchymal stem cells on three-dimensionally woven scaffolds.

Authors:  Benjamin L Larson; Sarah N Yu; Hyoungshin Park; Bradley T Estes; Franklin T Moutos; Cameron J Bloomquist; Patrick B Wu; Jean F Welter; Robert Langer; Farshid Guilak; Lisa E Freed
Journal:  J Tissue Eng Regen Med       Date:  2019-07-18       Impact factor: 3.963

4.  Absence of sclerostin adversely affects B-cell survival.

Authors:  Corey J Cain; Randell Rueda; Bryce McLelland; Nicole M Collette; Gabriela G Loots; Jennifer O Manilay
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

Review 5.  Skeletal stem cells: insights into maintaining and regenerating the skeleton.

Authors:  Maxwell A Serowoky; Claire E Arata; J Gage Crump; Francesca V Mariani
Journal:  Development       Date:  2020-03-11       Impact factor: 6.868

Review 6.  Transcription factor Runx2 and its application to bone tissue engineering.

Authors:  Luca Dalle Carbonare; Giulio Innamorati; Maria Teresa Valenti
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

7.  Effects of tricalcium silicate cements on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Ashraf A Eid; Khaled A Hussein; Li-na Niu; Guo-hua Li; Ikuya Watanabe; Mohamed Al-Shabrawey; David H Pashley; Franklin R Tay
Journal:  Acta Biomater       Date:  2014-04-13       Impact factor: 8.947

8.  Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development.

Authors:  Renée van Amerongen; Christophe Fuerer; Makiko Mizutani; Roel Nusse
Journal:  Dev Biol       Date:  2012-07-04       Impact factor: 3.582

9.  Cyclic AMP signaling in bone marrow stromal cells has reciprocal effects on the ability of mesenchymal stem cells to differentiate into mature osteoblasts versus mature adipocytes.

Authors:  Richard Kao; Weidar Lu; Alyssa Louie; Robert Nissenson
Journal:  Endocrine       Date:  2012-06-14       Impact factor: 3.633

Review 10.  Osteogenic Differentiation of Periosteal Cells During Fracture Healing.

Authors:  Tao Wang; Xinping Zhang; Daniel D Bikle
Journal:  J Cell Physiol       Date:  2016-10-26       Impact factor: 6.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.